Clinical trials
Phase 3 Dyslipidemias trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 16 |
| 2007 | 5 |
| 2008 | 10 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 17 |
| Abbott | 7 |
| Amgen | 5 |
| AstraZeneca | 5 |
| Novartis Pharmaceuticals | 4 |
| Amarin Pharma Inc. | 3 |
| Eisai Inc. | 3 |
| Kowa Research Institute, Inc. | 3 |
| NewAmsterdam Pharma | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 71 |
| Hypercholesterolemia | 22 |
| Hyperlipidemias | 22 |
| Diabetes Mellitus | 17 |
| Diabetes Mellitus, Type 2 | 14 |
| Glucose Metabolism Disorders | 13 |
| Cardiovascular Diseases | 12 |
| Coronary Disease | 8 |
| Hyperlipoproteinemia Type II | 8 |
| Hypertriglyceridemia | 7 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.